The Campbell Family Institute for Cancer Research

Amount
$100000
Date
October 2017

Defining the molecular mechanisms of DIPG development and progression to uncover novel therapeutic targets

Institute of Cancer Research

Amount
$102432
Date
October 2017

Combinational strategies alongside ACVR1 inhibition in DIPG

The Regents of the University of California

Amount
$70000
Date
October 2017

An Open Label Single Arm Phase I/II study of MTX110 delivered by convection-enhanced delivery (CED) in patients with diffuse intrinsic pontine glioma (DIPG) previously treated with external beam radiation therapy

The Hospital for Sick Children

Amount
$100560
Date
October 2017

MRI Guided Focused Ultrasound: Towards Clinical Translation in Diffuse Intrinsic Pontine Glioma (DIPG)

Texas Children's Hospital

Amount
$200000
Date
October 2017

Targeting DIPG through Combining a Super-activator (MCB-613) of Steroid Receptor Co-activators with Radiation

Gustave Roussy

Amount
$101868
Date
October 2017

Elucidating the underlying mechanisms of radio resistance at diagnosis and relapse in DIPG

Ospedale Pediatrico Bambino Gesu

Amount
$98987.89
Date
October 2017

Investigating the role of DIPG-derived exosomes in tumor growth and invasion

Memorial Sloan Kettering Cancer Center

Amount
$100000
Date
October 2017

Targeting EZH2 as a therapeutic strategy in DIPG